Osaic Holdings Inc. Sells 36,416 Shares of SPDR S&P Biotech ETF $XBI

Osaic Holdings Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 72,482 shares of the exchange traded fund’s stock after selling 36,416 shares during the quarter. Osaic Holdings Inc. owned 0.13% of SPDR S&P Biotech ETF worth $6,006,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Thrivent Financial for Lutherans increased its holdings in shares of SPDR S&P Biotech ETF by 75.5% during the second quarter. Thrivent Financial for Lutherans now owns 135,944 shares of the exchange traded fund’s stock worth $11,274,000 after purchasing an additional 58,499 shares during the period. Continental Advisors LLC grew its position in SPDR S&P Biotech ETF by 40.1% during the second quarter. Continental Advisors LLC now owns 36,700 shares of the exchange traded fund’s stock worth $3,044,000 after buying an additional 10,500 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in SPDR S&P Biotech ETF by 99.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,380 shares of the exchange traded fund’s stock worth $197,000 after acquiring an additional 1,189 shares during the period. Evergreen Capital Management LLC raised its holdings in SPDR S&P Biotech ETF by 32.1% in the 2nd quarter. Evergreen Capital Management LLC now owns 6,686 shares of the exchange traded fund’s stock valued at $554,000 after acquiring an additional 1,625 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $445,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $125.91 on Tuesday. The firm has a market cap of $7.64 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $126.50. The business’s fifty day moving average is $115.61 and its 200-day moving average is $99.12.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.